Innovation “Crisis” And Health Care Reform: Lilly CEO Urges Change In Focus
Executive Summary
Lilly CEO John Lechleiter is urging policy makers to focus on the "I word" - Innovation - in the context of the health care reform debate
You may also be interested in...
Lilly's Lechleiter Talks Innovation During Obama's Consultation With CEOs
Lilly's CEO was the sole representative of the biopharmaceutical industry participating in President Obama's meeting with the leaders of 20 large U.S. corporations.
Lilly's Lechleiter Talks Innovation During Obama's Consultation With CEOs
Lilly's CEO was the sole representative of the biopharmaceutical industry participating in President Obama's meeting with the leaders of 20 large U.S. corporations.
Bending The Cost Curve: Obama Presses For Specifics On Coalition Pledge
The White House is expecting a private sector healthcare coalition - including the pharmaceutical industry - to produce details in early June on a pledge to help reduce the annual health care spending growth rate by 1.5 percentage points over the next 10 years